Theodore James Jr. Washburn - 14 Feb 2023 Form 4 Insider Report for AGIOS PHARMACEUTICALS, INC. (AGIO)

Role: Principal Accounting Officer
Signature: /s/ William Cook, as attorney-in-fact for Theodore James Jr. Washburn
Issuer symbol: AGIO
Transactions as of: 14 Feb 2023
Net transactions value: -$18,081
Form type: 4
Filing time: 16 Feb 2023, 15:04:58 UTC
Previous filing: 14 Feb 2023
Next filing: 21 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AGIO	Common stock	Options Exercise	$0	+360	+11%	$0.000000	3,532	14 Feb 2023	Direct
transaction	AGIO	Common stock	Tax liability	$3,672	-127	-3.6%	$28.91	3,405	14 Feb 2023	Direct
transaction	AGIO	Common stock	Sale	$14,409	-504	-15%	$28.59	2,901	14 Feb 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AGIO	Restricted stock units	Options Exercise	$0	-360	-100%	$0.000000^*	0	14 Feb 2023	Common stock	360		Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F2	Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
F3	The restricted stock units were granted on February 14, 2020. Beginning on February 14, 2021, the shares underlying the restricted stock units will vest in three equal annual installments.